Waning Humoral Immune Response Following the Third and Fourth SARS‐COV‐2 Vaccine: A Cohort Study in Healthcare Workers

Author:

Süner Ahmet Furkan1ORCID,Ergör Gül1,Çağlayan Derya2,Türe Neslişah1,Güzel Irmak3,Irmak Çağlar4,Işık Elif1,Appak Özgür5,Çelik Muammer6,Öztürk Gamze5,Çavuş Sema Alp6,Sayiner Arzu5,Ergör Alp1,Demiral Yücel1,Kilic Bulent1

Affiliation:

1. Department of Public Health, Faculty of Medicine Dokuz Eylul University Izmir Turkey

2. Infectious Diseases Unit Diyarbakır Provincial Health Directorate Diyarbakir Turkey

3. Medical Microbiology Unit Mardin Nusaybin State Hospital Mardin Turkey

4. Infectious Diseases and Clinical Microbiology Unit Hakkari Yüksekova State Hospital Hakkari Turkey

5. Department of Medical Microbiology, Faculty of Medicine Dokuz Eylul University Izmir Turkey

6. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine Dokuz Eylul University Izmir Turkey

Abstract

ABSTRACTBackgroundThis study is aimed at providing information about the timing of booster doses and antibody kinetics in healthcare workers.MethodsThis research extends a prospective cohort study conducted at Dokuz Eylul University Hospital in Turkey, covering the period from March 2021 to December 2021. During this timeframe, the antibody levels of the health workers were measured at four different time points. The associations of antibody levels with gender, age, occupation, body mass index (BMI), chronic disease, and smoking were analyzed.ResultsThere was a significant difference between antibody levels in all four blood draws (p < 0.001). Antibody levels decreased in both those vaccinated with BNT162b2 (p < 0.001) and those vaccinated with CoronaVac (p = 0.002) until the fourth blood draw. There was a significant difference between those vaccinated with one and two doses of booster BNT162b2 before the third blood draw (p < 0.001), which continued at the fourth blood draw (p < 0.001). The antibody levels of those with an interval of 41–50 days between two vaccinations decreased significantly at the fourth blood draw (p < 0.001).ConclusionsThis study provides insight into the dynamics and persistence of antibody response after additional COVID‐19 vaccine doses among healthcare workers. The longer the interval between booster doses may result in greater antibody levels being maintained over time, allowing for longer durations of protection.

Publisher

Wiley

Reference47 articles.

1. Interim Recommendations for Use of the Pfizer–BioNTech COVID‐19 Vaccine BNT162b2 Under Emergency Use Listing [Internet] [cited 2023 Nov 16]. Available from:https://www.who.int/publications‐detail‐redirect/WHO‐2019‐nCoV‐vaccines‐SAGE_recommendation‐BNT162b2‐2021.1.

2. Interim Statement on Booster Doses for COVID‐19 Vaccination [Internet] [cited 2023 Nov 16]. Available from:https://www.who.int/news/item/04‐10‐2021‐interim‐statement‐on‐booster‐doses‐for‐covid‐19‐vaccination.

3. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study

4. Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study

5. D.Feikin M. M.Higdon L. J.Abu‐Raddad et al. Duration of Effectiveness of Vaccines Against SARS‐CoV‐2 Infection and COVID‐19 Disease: Results of a Systematic Review and Meta‐Regression [Internet] (2021) Rochester NY

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3